Awards as PI
| Funding | ||
|---|---|---|
| New Cell Lines | Safe, efficient creation of human induced pluripotent stem cells without the use of retroviruses | $1,406,875 |
| Early Translational II | Stem Cell Therapy for Duchenne Muscular Dystrophy | $2,325,933 |
| Tools and Technologies II | Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation | $1,619,627 |
Total: $5,352,435.00 |
